Skip to main content
SpringerLink
Log in

Behavioral Therapy in Combination with Pharmacotherapy

  • Chapter
  • First Online:
Book cover Contemporary Pharmacotherapy of Overactive Bladder

  • 487 Accesses

Abstract

Behavioral treatments (BT) are a group of therapies that aim to improve overactive bladder symptoms by modifying patient behavior or his/her environment. They may include bladder diary, timed voiding, delayed voiding, pelvic floor muscle training, urge suppression, biofeedback, electrical stimulation, fluid management, dietary changes, weight loss, and other lifestyle changes. Guidelines designate BT as first-line treatments because they are as effective in improving symptoms as pharmacological treatment and are relatively noninvasive and rarely associated with adverse events. However, they demand active participation of the patient as well as time and effort from the clinician. Behavioral and drug therapies are frequently used in combination in clinical practice to enhance patient symptom control and quality of life. A number of studies indicate that starting behavioral and pharmacological therapy simultaneously may improve outcomes. Alternatively, patients who are not significantly improved on behavioral or drug therapy alone may benefit from adding the alternate therapy in a stepped approach. In this chapter we review the use of behavioral therapy in combination with pharmacotherapy for the treatment of non-neurogenic overactive bladder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dumoulin C, Adewuyi T, Booth J, Bradley C, Burgio K, Hagen S, Hunter K, et al. Adult conservative management. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. International consultation on incontinence. 6th ed. 6th International Consultation on Incontinence, Tokyo, September 2016. pp. 1443–628. Bristol: The International Continence Society (ICS) and the International Consultation on Urological Diseases (ICUD); 2017.

    Google Scholar 

  2. Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C, et al. CUA guideline on adult overactive bladder. Can Urol Assoc J. 2017;11(5):E142–E73.

    Article  Google Scholar 

  3. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ; American Urological Association; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. 2012; amended 2014. http://www.auanet.org/guidelines/overactive-bladder-(oab)-(aua/sufu-guideline-2012-amended-2014). Accessed 27 Apr 2018.

  4. Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572–80.

    Article  Google Scholar 

  5. Burkhard FC, Bosch, JLHR, Cruz F, Lemack GE, Nambiar N, Thiruchelvam A, et al. EAU guidelines on urinary incontinence in adults. Arnhem: EAU Guidelines Office; 2017. http://uroweb.org/guideline/urinary-incontinence/. Accessed 26 Apr 2018.

  6. Fantl JA, Wyman JF, McClish DK, Harkins SW, Elswick RK, Taylor JR, et al. Efficacy of bladder training in older women with urinary incontinence. JAMA. 1991;265(5):609–13.

    Article  CAS  Google Scholar 

  7. Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA. 1998;280(23):1995–2000.

    Article  CAS  Google Scholar 

  8. Burgio KL, Goode PS, Johnson TM, Hammontree L, Ouslander JG, Markland AD, et al. Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) trial. J Am Geriatr Soc. 2011;59(12):2209–16.

    Article  Google Scholar 

  9. Goode PS, Burgio KL, Locher JL, Umlauf MG, Lloyd LK, Roth DL. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. J Am Geriatr Soc. 2002;50(5):808–16.

    Article  Google Scholar 

  10. Rai BP, Cody JD, Alhasso A, Stewart L. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2012;12:CD003193.

    PubMed  Google Scholar 

  11. Kaya S, Akbayrak T, Beksac S. Comparison of different treatment protocols in the treatment of idiopathic detrusor overactivity: a randomized controlled trial. Clin Rehabil. 2011;25(4):327–38.

    Article  Google Scholar 

  12. Burgio KL, Kraus SR, Menefee S, Borello-France D, Corton M, Johnson HW, et al. Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med. 2008;149(3):161–9.

    Article  Google Scholar 

  13. Mattiasson A, Masala A, Morton R, Bolodeoku J, Group SS. Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study. BJU Int. 2010;105(8):1126–35.

    Article  CAS  Google Scholar 

  14. Mattiasson A, Blaakaer J, Hoye K, Wein AJ, Tolterodine Scandinavian Study G. Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int. 2003;91(1):54–60.

    Article  CAS  Google Scholar 

  15. Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc. 2000;48(4):370–4.

    Article  CAS  Google Scholar 

  16. Borello-France D, Burgio KL, Goode PS, Markland AD, Kenton K, Balasubramanyam A, et al. Adherence to behavioral interventions for urge incontinence when combined with drug therapy: adherence rates, barriers, and predictors. Phys Ther. 2010;90(10):1493–505.

    Article  Google Scholar 

  17. Wein AJ. Diagnosis and treatment of the overactive bladder. Urology. 2003;62(5 Suppl 2):20–7.

    Article  Google Scholar 

  18. Elser DM, Wyman JF, McClish DK, Robinson D, Fantl JA, Bump RC. The effect of bladder training, pelvic floor muscle training, or combination training on urodynamic parameters in women with urinary incontinence. Continence Program for Women Research Group. Neurourol Urodyn. 1999;18(5):427–36.

    Article  CAS  Google Scholar 

  19. Burgio KL, Goode PS, Richter HE, Markland AD, Johnson TM 2nd, Redden DT. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women. J Urol. 2010;184(2):598–603.

    Article  Google Scholar 

  20. Millard RJ; Asia Pacific Tolterodine Study G. Clinical efficacy of tolterodine with or without a simplified pelvic floor exercise regimen. Neurourol Urodyn. 2004;23(1):48–53.

    Google Scholar 

  21. Yoshimura N, de Groat WC. Neural control of the lower urinary tract. Int J Urol. 1997;4(2):111–25.

    Article  CAS  Google Scholar 

  22. Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32(1):11–8.

    Article  Google Scholar 

  23. Bristow SE, Hasan ST, Neal DE. TENS: a treatment option for bladder dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(4):185–90.

    Article  CAS  Google Scholar 

  24. Vandoninck V, van Balken MR, Finazzi AE, Petta F, Micali F, Heesakkers JP, et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn. 2003;22(3):227–32.

    Article  Google Scholar 

  25. Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31(8):1206–16.

    Article  CAS  Google Scholar 

  26. Amend B, Matzel KE, Abrams P, de Groat WC, Sievert KD. How does neuromodulation work. Neurourol Urodyn. 2011;30(5):762–5.

    Article  Google Scholar 

  27. Van Kerrebroeck PE, Marcelissen TA. Sacral neuromodulation for lower urinary tract dysfunction. World J Urol. 2012;30(4):445–50.

    Article  Google Scholar 

  28. Sancaktar M, Ceyhan ST, Akyol I, Muhcu M, Alanbay I, Mutlu Ercan C, et al. The outcome of adding peripheral neuromodulation (Stoller afferent neuro-stimulation) to anti-muscarinic therapy in women with severe overactive bladder. Gynecol Endocrinol. 2010;26(10):729–32.

    Article  Google Scholar 

  29. Souto SC, Reis LO, Palma T, Palma P, Denardi F. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome. World J Urol. 2014;32(1):179–84.

    Article  CAS  Google Scholar 

  30. Cao Y, Lv J, Zhao C, Li J, Leng J. Cholinergic antagonists combined with electrical stimulation or bladder training treatments for overactive bladder in female adults: a meta-analysis of randomized controlled trials. Clin Drug Investig. 2016;36(10):801–8.

    Article  CAS  Google Scholar 

  31. Abulseoud A, Moussa A, Abdelfattah G, Ibrahim I, Saba E, Hassouna M. Transcutaneous posterior tibial nerve electrostimulation with low dose trospium chloride: could it be used as a second line treatment of overactive bladder in females. Neurourol Urodyn. 2018;37(22):842–8.

    Article  CAS  Google Scholar 

  32. Andersson KE, Cardozo L, Cruz F, Lee K-S, Suhai A, Wein AJ. Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence. 6th International Consultation on Incontinence, Tokyo, September 2016, pp. 805–957. The International Continence Society (ICS) and the International Consultation on Urological Diseases (ICUD); 2017.

    Google Scholar 

  33. Hextall A. Oestrogens and lower urinary tract function. Maturitas. 2000;36(2):83–92.

    Article  CAS  Google Scholar 

  34. Cardozo L, Rekers H, Tapp A, Barnick C, Shepherd A, Schussler B, et al. Oestriol in the treatment of postmenopausal urgency: a multicentre study. Maturitas. 1993;18(1):47–53.

    Article  CAS  Google Scholar 

  35. Rufford J, Hextall A, Cardozo L, Khullar V. A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(2):78–83.

    Article  Google Scholar 

  36. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol. 1998;92(4 Pt 2):722–7.

    CAS  PubMed  Google Scholar 

  37. Krause M, Wheeler TL 2nd, Richter HE, Snyder TE. Systemic effects of vaginally administered estrogen therapy: a review. Female Pelvic Med Reconstr Surg. 2010;16(3):188–95.

    Article  Google Scholar 

  38. Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;10:CD001405.

    PubMed  Google Scholar 

  39. Bhatia NN, Bergman A, Karram MM. Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol. 1989;160(1):176–81.

    Article  CAS  Google Scholar 

  40. Abdelbary AM, El-Dessoukey AA, Massoud AM, Moussa AS, Zayed AS, Elsheikh MG, et al. Combined vaginal pelvic floor electrical stimulation (PFS) and local vaginal estrogen for treatment of overactive bladder (OAB) in perimenopausal females. Randomized controlled trial (RCT). Urology. 2015;86(3):482–6.

    Article  Google Scholar 

  41. Maman K, Aballea S, Nazir J, Desroziers K, Neine ME, Siddiqui E, et al. Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. Eur Urol. 2014;65(4):755–65.

    Article  CAS  Google Scholar 

  42. Quintiliano F, Veiga ML, Moraes M, Cunha C, de Oliveira LF, Lordelo P, et al. Transcutaneous parasacral electrical stimulation vs oxybutynin for the treatment of overactive bladder in children: a randomized clinical trial. J Urol. 2015;193(5 Suppl):1749–53.

    Article  CAS  Google Scholar 

  43. Borch L, Hagstroem S, Kamperis K, Siggaard CV, Rittig S. Transcutaneous electrical nerve stimulation combined with oxybutynin is superior to monotherapy in children with urge incontinence: a randomized, placebo controlled study. J Urol. 2017;198(2):430–5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital of the University of Sao Paulo School of Medicine, Division of Urology, Sao Paulo, Brazil

    Cristiano Mendes Gomes & Marcelo Hisano

Authors
  1. Cristiano Mendes Gomes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcelo Hisano
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Medical University of South Carolina, Charleston, SC, USA

    Lindsey Cox

  2. Department of Urology, Medical University of South Carolina, Charleston, SC, USA

    Eric S. Rovner

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gomes, C.M., Hisano, M. (2019). Behavioral Therapy in Combination with Pharmacotherapy. In: Cox, L., Rovner, E. (eds) Contemporary Pharmacotherapy of Overactive Bladder. Springer, Cham. https://doi.org/10.1007/978-3-319-97265-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97265-7_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-97264-0

  • Online ISBN: 978-3-319-97265-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation